Recent News

• 06.17.2025 - Investor Event on Brepocitinib
• 06.10.2025 - Fireside Chat – Goldman Sachs Global Healthcare Conference
• 06.10.2025 - Fireside Chat – Goldman Sachs Global Healthcare Conference
• 06.09.2025 - Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in Dermatomyositis
• 06.05.2025 - Fireside Chat – Jefferies Healthcare Conference
• 05.29.2025 - Roivant 4Q 2024 Earnings Call
• 05.29.2025 - Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update

Recent Filings

• 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.06.2025 - 144 Report of proposed sale of securities
• 06.04.2025 - 144 Report of proposed sale of securities
• 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2025 - 144 Report of proposed sale of securities
• 06.02.2025 - 144 Report of proposed sale of securities
• 05.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 05.29.2025 - EX-99.1 EX-99.1
• 05.29.2025 - 8-K Current report